Real World Evidence Solutions Market Size, Share & Trends Analysis Report By Component (Services, Datasets), By Application (Drug Development & Approvals), By End-user, By Therapeutic Area, By Region, And Segment Forecasts, 2023 - 2030
This report can be delivered to the clients within Immediate
Real World Evidence Solutions Market Growth & Trends
The global real world evidence solutions market size is expected to reach USD 78.80 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.2% from 2023 to 2030. The key factors driving the real-world evidence (RWE) solutions market include favorable government regulations and a shift from volume to value-based care. Furthermore, the increasing prevalence of chronic disorders is anticipated to positively influence market growth.
During the pandemic, companies in the RWE solutions market diverted their focus on providing solutions for curbing the spread of COVID-19. For instance, IBM collaborated with Salesforce for building digital health passes, which incorporated data such as vaccine status, temperature checks, and COVID-19 test results for helping organizations to reopen safely. It also partnered with ServiceNow on Watson AIOps for supporting it to continue its leadership in transformative artificial intelligence by helping clients automate IT operations and reduce risks.
According to PerkinElmer, real-world evidence solutions offer around USD 300 to 500 Billion in top-down opportunity for the U.S. healthcare industry alone. In addition, many life science companies are witnessing ad hoc value from selected RWE case studies and demonstrating around USD 100 million of bottom-up impact. Therefore, if a company captures USD 1 billion in real-world evidence value, it ultimately creates more than USD tens of billions in terms of healthcare improvements. This is anticipated to boost market growth.
The adoption and usage of RWE solutions are higher in developed markets of North America and Europe owing to supportive initiatives by legal, government, and other regulatory bodies. For instance, in October 2021, FDA selected the Aetion Evidence Platform to use RWE to analyze COVID-19 interventions and further regulatory science and innovation. Initiatives by regulatory agencies are supporting the expansion of RWE from post-market safety monitoring to other applications, such as for clinical trial design and observational studies and to substantiate coverage decisions.
Market players are investing in many strategic initiatives, such as acquisitions, mergers, partnerships, and product launches, to maintain a competitive edge in the market. For instance, in August 2021, Syneos Health partnered with Action for offering RWE solutions for advanced drug development and commercialization. This partnership brought together Syneos Health’s proprietary data collection research solutions and Aetion’s Evidence platform, AEP, for generating evidence through patient data curation and real world data.
Real World Evidence Solutions Market Report Highlights
Real World Evidence Solutions Market Growth & Trends
The global real world evidence solutions market size is expected to reach USD 78.80 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.2% from 2023 to 2030. The key factors driving the real-world evidence (RWE) solutions market include favorable government regulations and a shift from volume to value-based care. Furthermore, the increasing prevalence of chronic disorders is anticipated to positively influence market growth.
During the pandemic, companies in the RWE solutions market diverted their focus on providing solutions for curbing the spread of COVID-19. For instance, IBM collaborated with Salesforce for building digital health passes, which incorporated data such as vaccine status, temperature checks, and COVID-19 test results for helping organizations to reopen safely. It also partnered with ServiceNow on Watson AIOps for supporting it to continue its leadership in transformative artificial intelligence by helping clients automate IT operations and reduce risks.
According to PerkinElmer, real-world evidence solutions offer around USD 300 to 500 Billion in top-down opportunity for the U.S. healthcare industry alone. In addition, many life science companies are witnessing ad hoc value from selected RWE case studies and demonstrating around USD 100 million of bottom-up impact. Therefore, if a company captures USD 1 billion in real-world evidence value, it ultimately creates more than USD tens of billions in terms of healthcare improvements. This is anticipated to boost market growth.
The adoption and usage of RWE solutions are higher in developed markets of North America and Europe owing to supportive initiatives by legal, government, and other regulatory bodies. For instance, in October 2021, FDA selected the Aetion Evidence Platform to use RWE to analyze COVID-19 interventions and further regulatory science and innovation. Initiatives by regulatory agencies are supporting the expansion of RWE from post-market safety monitoring to other applications, such as for clinical trial design and observational studies and to substantiate coverage decisions.
Market players are investing in many strategic initiatives, such as acquisitions, mergers, partnerships, and product launches, to maintain a competitive edge in the market. For instance, in August 2021, Syneos Health partnered with Action for offering RWE solutions for advanced drug development and commercialization. This partnership brought together Syneos Health’s proprietary data collection research solutions and Aetion’s Evidence platform, AEP, for generating evidence through patient data curation and real world data.
Real World Evidence Solutions Market Report Highlights
- Favorable government initiatives and a shift from volume to value-based care are expected to boost the market growth
- The services component segment led the market in 2022 owing to its increasing demand over the forecast period
- The drug development and approvals application segment dominated the market in 2022 owing to the rising adoption of RWE solutions in pharmaceutical companies for this application
- The healthcare payers' end-user segment is anticipated to expand at the fastest CAGR over the forecast period owing to the increasing awareness among payers regarding drug and medical device safety
- North America led the global market in 2022 with a revenue share of more than 40.0% owing to the presence of major players in the region
- Asia Pacific is expected to be the fastest-growing regional market from 2023 to 2030 owing to the presence of contract research organizations in the region
- The market is fairly competitive. For instance, in April 2021, Thermo Fisher Scientific announced that it is set to acquire PPD, Inc. for USD 47.50 per share
CHAPTER 1 RESEARCH METHODOLOGY & SCOPE
1.1 Market Segmentation and Scope
1.1.1 Components
1.1.2 Application
1.1.3 End-User
1.1.4 Region
1.1.5 Estimates and forecast timeline
1.2 Research methodology
1.3 Information procurement
1.3.1 Purchased database
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.3.5.1 Data for primary interviews in North America
1.3.5.2 Data for primary interviews in Europe
1.3.5.3 Data for primary interviews in Asia Pacific
1.3.5.4 Data for primary interviews in Latin America
1.3.5.5 Data for primary interviews in Middle East & Africa
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective
1.10.2 Objective
1.10.3 Objective
1.10.4 Objective
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
CHAPTER 3 REAL WORLD EVIDENCE (RWE) SOLUTIONS MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Ancillary market outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Favorable government regulations
3.3.1.2 Shift from volume-to-value based care
3.3.2 Market restraint analysis
3.3.2.1 Lack of Standards
3.3.3 Market Opportunity Analysis
3.3.4 Market Challenges Analysis
3.4 Real World Evidence (RWE) Solutions: Market Analysis Tools
3.4.1 Industry analysis - Porter’s
3.4.1.1 Bargaining power of buyers:
3.4.1.2 Bargaining power of suppliers:
3.4.1.3 Competitive rivalry:
3.4.1.4 Threat of new entrants:
3.4.1.5 Threat of substitutes:
3.4.2 PESTLE analysis
3.4.2.1 Political landscape
3.4.2.2 Environmental landscape
3.4.2.3 Social landscape
3.4.2.4 Technology landscape
3.4.2.5 Legal landscape
3.4.2.6 Economic landscape
3.5 Regulatory Framework
3.6 Pricing Model Analysis
3.6.1 Pay Per Usage
3.6.2 Pay Per Patient Record
3.6.3 Annual Subscription
CHAPTER 4 IMPACT OF COVID-19 ON REAL WORLD EVIDENCE (RWE) SOLUTIONS MARKET
4.1 Disease Prevalence Analysis
4.2 Current and Future Impact Analysis
4.3 Impact of COVID-19 on Market Players
4.4. Opportunity Analysis
CHAPTER 5 REAL WORLD EVIDENCE (RWE) SOLUTIONS MARKET: COMPONENT ESTIMATES AND FORECASTS TO 2030
5.1 Definition and Scope
5.2 Component Type Market Share Analysis, 2022 & 2030
5.3 Segment Dashboard
5.4 Global Real World Evidence (RWE) Solutions Market, by Component, 2018 to 2030
5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
5.5.1 Services
5.5.1.1 Services market, 2018 - 2030 (USD Million)
5.5.2 Data Sets
5.5.2.1 Data Sets market, 2018 - 2030 (USD Million)
5.5.2.2 Clinical Settings Data
5.5.2.2.1 Clinical Settings Data market, 2018 - 2030 (USD Million)
5.5.2.3 Claims Data
5.5.2.3.1 Claims Data market, 2018 - 2030 (USD Million)
5.5.2.4 Pharmacy Data
5.5.2.4.1 Pharmacy Data market, 2018 - 2030 (USD Million)
5.5.2.5 Patient-Powered Data
5.5.2.5.1 Patient-Powered Data market, 2018 - 2030 (USD Million)
CHAPTER 6 REAL WORLD EVIDENCE (RWE) SOLUTIONS MARKET: APPLICATION ESTIMATES AND FORECASTS TO 2030
6.1 Definition and Scope
6.2 Application Market Share Analysis, 2022 & 2030
6.3 Segment Dashboard
6.4 Global Real World Evidence (RWE) Solutions Market, by Application, 2018 to 2030
6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
6.5.1 Drug Development & Approvals
6.5.1.1 Drug Development & Approvals market, 2018 - 2030 (USD Million)
6.5.2 Medical Device Development & Approvals
6.5.2.1 Medical Device Development & Approvals market, 2018 - 2030 (USD Million)
6.5.3 Reimbursement/Coverage & Regulatory Decision Making
6.5.3.1 Reimbursement/Coverage & Regulatory Decision Making market, 2018 - 2030 (USD Million)
6.5.4 Post Market Safety & Adverse Events Monitoring
6.5.4.1 Post Market Safety & Adverse Events Monitoring market, 2018 - 2030 (USD Million)
CHAPTER 7 REAL WORLD EVIDENCE (RWE) SOLUTIONS MARKET: END-USE ESTIMATES AND FORECASTS TO 2030
7.1 Definition and Scope
7.2 End-user Market Share Analysis, 2022 & 2030
7.3 Segment Dashboard
7.4 Global Real World Evidence (RWE) Solutions Market, by end-user, 2018 to 2030
7.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
7.5.1 Healthcare Companies (Pharmaceutical, Biopharmaceutical, Medical Device)
7.5.1.1 Healthcare Companies market, 2018 - 2030 (USD Million)
7.5.1.2 Healthcare Companies market, Clinical Research, 2018 - 2030 (USD Million)
7.5.1.3 Healthcare Companies market, Commercial (inclusive of marketing, etc.), 2018 - 2030 (USD Million)
7.5.1.4 Healthcare Companies market, HEOR, 2018 - 2030 (USD Million)
7.5.1.5 Healthcare Companies market, Others (market access, etc.), 2018 - 2030 (USD Million)
7.5.2 Healthcare Payers
7.5.2.1 Healthcare Payers market, 2018 - 2030 (USD Million)
7.5.3 Healthcare Providers
7.5.3.1 Healthcare Providers market, 2018 - 2030 (USD Million)
7.5.4 Others
7.5.4.1 Others market, 2018 - 2030 (USD Million)
CHAPTER 8 REAL WORLD EVIDENCE (RWE) SOLUTIONS MARKET: THERAPEUTIC AREA ESTIMATES AND FORECASTS TO 2030
8.1 Definition and Scope
8.2 Therapeutic Area Market Share Analysis, 2022 & 2030
8.3 Segment Dashboard
8.4 Global Real World Evidence (RWE) Solutions Market, by Therapeutic Area, 2018 to 2030
8.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
8.5.1 Oncology
8.5.1.1 Oncology market, 2018 - 2030 (USD Million)
8.5.2 Cardiology
8.5.2.1 Cardiology market, 2018 - 2030 (USD Million)
8.5.3 Neurology
8.5.3.1 Neurology market, 2018 - 2030 (USD Million)
8.5.4 Diabetes
8.5.4.1 Diabetes market, 2018 - 2030 (USD Million)
8.5.5 Psychiatry
8.5.5.1 Psychiatry market, 2018 - 2030 (USD Million)
8.5.6 Respiratory
8.5.6.1 Respiratory market, 2018 - 2030 (USD Million)
8.5.7 Other therapeutic areas (Immunology, Gastroenterology, etc.)
8.5.7.1 Other therapeutic areas market, 2018 - 2030 (USD Million)
CHAPTER 9 REAL WORLD EVIDENCE (RWE) SOLUTIONS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS, BY COMPONENT, APPLICATION, END-USER
9.1 Definition and Scope
9.2 Regional Market Share Analysis, 2022 & 2030
9.3 North America
9.3.1 North America Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.3.1.1 U.S.
9.3.1.1.1 U.S. Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.3.1.2 Canada
9.3.1.2.1 Canada Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.4 Europe
9.4.1 Europe Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.4.1.1 U.K.
9.4.1.1.1 U.K. Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.4.1.2 Germany
9.4.1.2.1 Germany Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.4.1.3 France
9.4.1.3.1 France Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.4.1.4 Italy
9.4.1.4.1 Italy Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.4.1.5 Spain
9.4.1.5.1 Spain Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.5 Asia Pacific
9.5.1 Asia Pacific Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.5.1.1 Japan
9.5.1.1.1 Japan Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.5.1.2 China
9.5.1.2.1 China Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.5.1.3 India
9.5.1.3.1 India Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.5.1.4 Australia
9.5.1.4.1 Australia Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.5.1.5 South Korea
9.5.1.5.1 South Korea Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.6. Latin America
9.6.1 Latin America Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.6.1.1 Brazil
9.6.1.1.1 Brazil Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.6.1.2 Mexico
9.6.1.2.1 Mexico Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.6.1.3 Argentina
9.6.1.3.1 Argentina Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.7 MEA
9.7.1 MEA Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.7.1.1 South Africa
9.7.1.1.1 South Africa Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.7.1.2 Saudi Arabia
9.7.1.2.1 Saudi Arabia Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.7.1.3 Israel
9.7.1.3.1 Israel Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
CHAPTER 10 REAL WORLD EVIDENCE (RWE) SOLUTIONS MARKET: COMPETITIVE ANALYSIS
10.1 Market Participation Categorization
10.2 Competitive Dashboard Analysis
10.3 Public Companies
10.3.1 Company Market Share/Position Analysis
10.3.2 Heat Map Analysis
10.4 Private Companies
10.4.1 List of Key Companies
CHAPTER 11 COMPANY PROFILES
11.1 IQVIA
11.1.1 Company Overview
11.1.2 Financial Performance
11.1.3 Product Benchmarking
11.1.4 Strategic Initiatives
11.2 IBM
11.2.1 Company Overview
11.2.2 Financial Performance
11.2.3 Product Benchmarking
11.2.4 Strategic Initiatives
11.3 PPD Inc.
11.3.1 Company Overview
11.3.2 Financial Performance
11.3.3 Product Benchmarking
11.3.4 Strategic Initiatives
11.4 Parexel International Corporation
11.4.1 Company Overview
11.4.2 Financial Performance
11.4.3 Product Benchmarking
11.4.4 Strategic Initiatives
11.5 PerkinElmer Inc.
11.5.1 Company Overview
11.5.2 Financial Performance
11.5.3 Product Benchmarking
11.5.4 Strategic Initiatives
11.6 Icon Plc
11.6.1 Company Overview
11.6.2 Financial Performance
11.6.3 Product Benchmarking
11.6.4 Strategic Initiatives
11.7 Oracle
11.7.1 Company Overview
11.7.2 Financial Performance
11.7.3 Product Benchmarking
11.7.4 Strategic Initiatives
11.8 Syneos Health
11.8.1 Company Overview
11.8.2 Financial Performance
11.8.3 Product Benchmarking
11.8.4 Strategic Initiatives
11.9 Cegedim Health Data
11.9.1 Company Overview
11.9.2 Financial Performance
11.9.3 Product Benchmarking
11.9.4 Strategic Initiatives
11.10 Medpace
11.10.1 Company Overview
11.10.2 Financial Performance
11.10.3 Product Benchmarking
11.10.4 Strategic Initiatives
1.1 Market Segmentation and Scope
1.1.1 Components
1.1.2 Application
1.1.3 End-User
1.1.4 Region
1.1.5 Estimates and forecast timeline
1.2 Research methodology
1.3 Information procurement
1.3.1 Purchased database
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.3.5.1 Data for primary interviews in North America
1.3.5.2 Data for primary interviews in Europe
1.3.5.3 Data for primary interviews in Asia Pacific
1.3.5.4 Data for primary interviews in Latin America
1.3.5.5 Data for primary interviews in Middle East & Africa
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective
1.10.2 Objective
1.10.3 Objective
1.10.4 Objective
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
CHAPTER 3 REAL WORLD EVIDENCE (RWE) SOLUTIONS MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Ancillary market outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Favorable government regulations
3.3.1.2 Shift from volume-to-value based care
3.3.2 Market restraint analysis
3.3.2.1 Lack of Standards
3.3.3 Market Opportunity Analysis
3.3.4 Market Challenges Analysis
3.4 Real World Evidence (RWE) Solutions: Market Analysis Tools
3.4.1 Industry analysis - Porter’s
3.4.1.1 Bargaining power of buyers:
3.4.1.2 Bargaining power of suppliers:
3.4.1.3 Competitive rivalry:
3.4.1.4 Threat of new entrants:
3.4.1.5 Threat of substitutes:
3.4.2 PESTLE analysis
3.4.2.1 Political landscape
3.4.2.2 Environmental landscape
3.4.2.3 Social landscape
3.4.2.4 Technology landscape
3.4.2.5 Legal landscape
3.4.2.6 Economic landscape
3.5 Regulatory Framework
3.6 Pricing Model Analysis
3.6.1 Pay Per Usage
3.6.2 Pay Per Patient Record
3.6.3 Annual Subscription
CHAPTER 4 IMPACT OF COVID-19 ON REAL WORLD EVIDENCE (RWE) SOLUTIONS MARKET
4.1 Disease Prevalence Analysis
4.2 Current and Future Impact Analysis
4.3 Impact of COVID-19 on Market Players
4.4. Opportunity Analysis
CHAPTER 5 REAL WORLD EVIDENCE (RWE) SOLUTIONS MARKET: COMPONENT ESTIMATES AND FORECASTS TO 2030
5.1 Definition and Scope
5.2 Component Type Market Share Analysis, 2022 & 2030
5.3 Segment Dashboard
5.4 Global Real World Evidence (RWE) Solutions Market, by Component, 2018 to 2030
5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
5.5.1 Services
5.5.1.1 Services market, 2018 - 2030 (USD Million)
5.5.2 Data Sets
5.5.2.1 Data Sets market, 2018 - 2030 (USD Million)
5.5.2.2 Clinical Settings Data
5.5.2.2.1 Clinical Settings Data market, 2018 - 2030 (USD Million)
5.5.2.3 Claims Data
5.5.2.3.1 Claims Data market, 2018 - 2030 (USD Million)
5.5.2.4 Pharmacy Data
5.5.2.4.1 Pharmacy Data market, 2018 - 2030 (USD Million)
5.5.2.5 Patient-Powered Data
5.5.2.5.1 Patient-Powered Data market, 2018 - 2030 (USD Million)
CHAPTER 6 REAL WORLD EVIDENCE (RWE) SOLUTIONS MARKET: APPLICATION ESTIMATES AND FORECASTS TO 2030
6.1 Definition and Scope
6.2 Application Market Share Analysis, 2022 & 2030
6.3 Segment Dashboard
6.4 Global Real World Evidence (RWE) Solutions Market, by Application, 2018 to 2030
6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
6.5.1 Drug Development & Approvals
6.5.1.1 Drug Development & Approvals market, 2018 - 2030 (USD Million)
6.5.2 Medical Device Development & Approvals
6.5.2.1 Medical Device Development & Approvals market, 2018 - 2030 (USD Million)
6.5.3 Reimbursement/Coverage & Regulatory Decision Making
6.5.3.1 Reimbursement/Coverage & Regulatory Decision Making market, 2018 - 2030 (USD Million)
6.5.4 Post Market Safety & Adverse Events Monitoring
6.5.4.1 Post Market Safety & Adverse Events Monitoring market, 2018 - 2030 (USD Million)
CHAPTER 7 REAL WORLD EVIDENCE (RWE) SOLUTIONS MARKET: END-USE ESTIMATES AND FORECASTS TO 2030
7.1 Definition and Scope
7.2 End-user Market Share Analysis, 2022 & 2030
7.3 Segment Dashboard
7.4 Global Real World Evidence (RWE) Solutions Market, by end-user, 2018 to 2030
7.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
7.5.1 Healthcare Companies (Pharmaceutical, Biopharmaceutical, Medical Device)
7.5.1.1 Healthcare Companies market, 2018 - 2030 (USD Million)
7.5.1.2 Healthcare Companies market, Clinical Research, 2018 - 2030 (USD Million)
7.5.1.3 Healthcare Companies market, Commercial (inclusive of marketing, etc.), 2018 - 2030 (USD Million)
7.5.1.4 Healthcare Companies market, HEOR, 2018 - 2030 (USD Million)
7.5.1.5 Healthcare Companies market, Others (market access, etc.), 2018 - 2030 (USD Million)
7.5.2 Healthcare Payers
7.5.2.1 Healthcare Payers market, 2018 - 2030 (USD Million)
7.5.3 Healthcare Providers
7.5.3.1 Healthcare Providers market, 2018 - 2030 (USD Million)
7.5.4 Others
7.5.4.1 Others market, 2018 - 2030 (USD Million)
CHAPTER 8 REAL WORLD EVIDENCE (RWE) SOLUTIONS MARKET: THERAPEUTIC AREA ESTIMATES AND FORECASTS TO 2030
8.1 Definition and Scope
8.2 Therapeutic Area Market Share Analysis, 2022 & 2030
8.3 Segment Dashboard
8.4 Global Real World Evidence (RWE) Solutions Market, by Therapeutic Area, 2018 to 2030
8.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
8.5.1 Oncology
8.5.1.1 Oncology market, 2018 - 2030 (USD Million)
8.5.2 Cardiology
8.5.2.1 Cardiology market, 2018 - 2030 (USD Million)
8.5.3 Neurology
8.5.3.1 Neurology market, 2018 - 2030 (USD Million)
8.5.4 Diabetes
8.5.4.1 Diabetes market, 2018 - 2030 (USD Million)
8.5.5 Psychiatry
8.5.5.1 Psychiatry market, 2018 - 2030 (USD Million)
8.5.6 Respiratory
8.5.6.1 Respiratory market, 2018 - 2030 (USD Million)
8.5.7 Other therapeutic areas (Immunology, Gastroenterology, etc.)
8.5.7.1 Other therapeutic areas market, 2018 - 2030 (USD Million)
CHAPTER 9 REAL WORLD EVIDENCE (RWE) SOLUTIONS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS, BY COMPONENT, APPLICATION, END-USER
9.1 Definition and Scope
9.2 Regional Market Share Analysis, 2022 & 2030
9.3 North America
9.3.1 North America Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.3.1.1 U.S.
9.3.1.1.1 U.S. Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.3.1.2 Canada
9.3.1.2.1 Canada Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.4 Europe
9.4.1 Europe Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.4.1.1 U.K.
9.4.1.1.1 U.K. Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.4.1.2 Germany
9.4.1.2.1 Germany Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.4.1.3 France
9.4.1.3.1 France Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.4.1.4 Italy
9.4.1.4.1 Italy Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.4.1.5 Spain
9.4.1.5.1 Spain Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.5 Asia Pacific
9.5.1 Asia Pacific Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.5.1.1 Japan
9.5.1.1.1 Japan Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.5.1.2 China
9.5.1.2.1 China Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.5.1.3 India
9.5.1.3.1 India Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.5.1.4 Australia
9.5.1.4.1 Australia Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.5.1.5 South Korea
9.5.1.5.1 South Korea Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.6. Latin America
9.6.1 Latin America Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.6.1.1 Brazil
9.6.1.1.1 Brazil Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.6.1.2 Mexico
9.6.1.2.1 Mexico Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.6.1.3 Argentina
9.6.1.3.1 Argentina Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.7 MEA
9.7.1 MEA Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.7.1.1 South Africa
9.7.1.1.1 South Africa Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.7.1.2 Saudi Arabia
9.7.1.2.1 Saudi Arabia Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
9.7.1.3 Israel
9.7.1.3.1 Israel Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
CHAPTER 10 REAL WORLD EVIDENCE (RWE) SOLUTIONS MARKET: COMPETITIVE ANALYSIS
10.1 Market Participation Categorization
10.2 Competitive Dashboard Analysis
10.3 Public Companies
10.3.1 Company Market Share/Position Analysis
10.3.2 Heat Map Analysis
10.4 Private Companies
10.4.1 List of Key Companies
CHAPTER 11 COMPANY PROFILES
11.1 IQVIA
11.1.1 Company Overview
11.1.2 Financial Performance
11.1.3 Product Benchmarking
11.1.4 Strategic Initiatives
11.2 IBM
11.2.1 Company Overview
11.2.2 Financial Performance
11.2.3 Product Benchmarking
11.2.4 Strategic Initiatives
11.3 PPD Inc.
11.3.1 Company Overview
11.3.2 Financial Performance
11.3.3 Product Benchmarking
11.3.4 Strategic Initiatives
11.4 Parexel International Corporation
11.4.1 Company Overview
11.4.2 Financial Performance
11.4.3 Product Benchmarking
11.4.4 Strategic Initiatives
11.5 PerkinElmer Inc.
11.5.1 Company Overview
11.5.2 Financial Performance
11.5.3 Product Benchmarking
11.5.4 Strategic Initiatives
11.6 Icon Plc
11.6.1 Company Overview
11.6.2 Financial Performance
11.6.3 Product Benchmarking
11.6.4 Strategic Initiatives
11.7 Oracle
11.7.1 Company Overview
11.7.2 Financial Performance
11.7.3 Product Benchmarking
11.7.4 Strategic Initiatives
11.8 Syneos Health
11.8.1 Company Overview
11.8.2 Financial Performance
11.8.3 Product Benchmarking
11.8.4 Strategic Initiatives
11.9 Cegedim Health Data
11.9.1 Company Overview
11.9.2 Financial Performance
11.9.3 Product Benchmarking
11.9.4 Strategic Initiatives
11.10 Medpace
11.10.1 Company Overview
11.10.2 Financial Performance
11.10.3 Product Benchmarking
11.10.4 Strategic Initiatives
LIST OF TABLES
Table 1 List of primary sources
Table 2 List of secondary sources
Table 3 North America Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 4 North America Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 5 North America Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 6 North America Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 7 North America Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 8 U.S. Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 9 U.S. Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 10 U.S. Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 11 U.S. Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 12 U.S. Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 13 Canada Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 14 Canada Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 15 Canada Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 16 Canada Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 17 Canada Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 18 Europe Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 19 Europe Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 20 Europe Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 21 Europe Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 22 Europe Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 23 U.K. Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 24 U.K. Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 25 U.K. Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 26 U.K. Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 27 U.K. Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 28 Germany Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 29 Germany Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 30 Germany Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 31 Germany Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 32 Germany Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 33 France Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 34 France Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 35 France Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 36 France Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 37 France Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 38 Italy Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 39 Italy Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 40 Italy Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 41 Italy Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 42 Italy Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 43 Spain Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 44 Spain Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 45 Spain Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 46 Spain Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 47 Spain Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 48 Asia Pacific Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 49 Asia Pacific Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 50 Asia Pacific Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 51 Asia Pacific Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 52 Asia Pacific Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 53 Japan Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 54 Japan Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 55 Japan Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 56 Japan Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 57 Japan Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 58 China Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 59 China Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 60 China Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 61 China Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 62 China Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 63 India Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 64 India Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 65 India Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 66 India Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 67 India Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 68 Australia Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 69 Australia Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 70 Australia Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 71 Australia Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 72 Australia Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 73 South Korea Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 74 South Korea Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 75 South Korea Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 76 South Korea Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 77 South Korea Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 78 Latin America Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 79 Latin America Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 80 Latin America Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 81 Latin America Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 82 Latin America Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 83 Brazil Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 84 Brazil Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 85 Brazil Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 86 Brazil Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 87 Brazil Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 88 Mexico Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 89 Mexico Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 90 Mexico Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 91 Mexico Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 92 Mexico Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 93 Argentina Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 94 Argentina Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 95 Argentina Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 96 Argentina Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 97 Argentina Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 98 MEA Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 99 MEA Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 100 MEA Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 101 MEA Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 102 MEA Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 103 South Africa Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 104 South Africa Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 105 South Africa Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 106 South Africa Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 107 South Africa Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 108 Saudi Arabia Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 109 Saudi Arabia Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 110 Saudi Arabia Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 111 Saudi Arabia Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 112 Saudi Arabia Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 113 Israel Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 114 Israel Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 115 Israel Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 116 Israel Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 117 Israel Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 1 List of primary sources
Table 2 List of secondary sources
Table 3 North America Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 4 North America Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 5 North America Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 6 North America Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 7 North America Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 8 U.S. Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 9 U.S. Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 10 U.S. Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 11 U.S. Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 12 U.S. Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 13 Canada Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 14 Canada Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 15 Canada Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 16 Canada Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 17 Canada Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 18 Europe Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 19 Europe Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 20 Europe Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 21 Europe Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 22 Europe Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 23 U.K. Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 24 U.K. Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 25 U.K. Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 26 U.K. Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 27 U.K. Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 28 Germany Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 29 Germany Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 30 Germany Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 31 Germany Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 32 Germany Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 33 France Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 34 France Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 35 France Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 36 France Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 37 France Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 38 Italy Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 39 Italy Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 40 Italy Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 41 Italy Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 42 Italy Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 43 Spain Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 44 Spain Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 45 Spain Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 46 Spain Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 47 Spain Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 48 Asia Pacific Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 49 Asia Pacific Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 50 Asia Pacific Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 51 Asia Pacific Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 52 Asia Pacific Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 53 Japan Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 54 Japan Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 55 Japan Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 56 Japan Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 57 Japan Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 58 China Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 59 China Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 60 China Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 61 China Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 62 China Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 63 India Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 64 India Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 65 India Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 66 India Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 67 India Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 68 Australia Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 69 Australia Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 70 Australia Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 71 Australia Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 72 Australia Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 73 South Korea Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 74 South Korea Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 75 South Korea Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 76 South Korea Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 77 South Korea Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 78 Latin America Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 79 Latin America Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 80 Latin America Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 81 Latin America Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 82 Latin America Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 83 Brazil Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 84 Brazil Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 85 Brazil Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 86 Brazil Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 87 Brazil Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 88 Mexico Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 89 Mexico Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 90 Mexico Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 91 Mexico Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 92 Mexico Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 93 Argentina Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 94 Argentina Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 95 Argentina Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 96 Argentina Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 97 Argentina Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 98 MEA Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 99 MEA Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 100 MEA Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 101 MEA Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 102 MEA Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 103 South Africa Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 104 South Africa Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 105 South Africa Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 106 South Africa Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 107 South Africa Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 108 Saudi Arabia Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 109 Saudi Arabia Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 110 Saudi Arabia Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 111 Saudi Arabia Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 112 Saudi Arabia Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
Table 113 Israel Real World Evidence (RWE) Solutions market, by Component, 2018 - 2030 (USD Million)
Table 114 Israel Real World Evidence (RWE) Solutions data sets market, by type, 2018 - 2030 (USD Million)
Table 115 Israel Real World Evidence (RWE) Solutions market, by applications, 2018 - 2030 (USD Million)
Table 116 Israel Real World Evidence (RWE) Solutions market, by end-user, 2018 - 2030 (USD Million)
Table 117 Israel Real World Evidence (RWE) Solutions market, by therapeutic area, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market summary
Fig. 2 Market trends & outlook
Fig. 3 Market segmentation & scope
Fig. 4 Market driver relevance analysis (Current & future impact)
Fig. 5 Market restraint relevance analysis (Current & future impact)
Fig. 6 Penetration & growth prospect mapping
Fig. 7 SWOT Analysis, By Factor (political & legal, economic and technological)
Fig. 8 Real World Evidence (RWE) Solutions: Porter’s Analysis
Fig. 9 Real World Evidence (RWE) Solutions market, Component outlook key takeaways
Fig. 10 Real World Evidence (RWE) Solutions market: Component movement analysis
Fig. 11 Global Services market, 2018 - 2030 (USD Million)
Fig. 12 Global Data Sets market, 2018 - 2030 (USD Million)
Fig. 13 Global Clinical Settings Data market, 2018 - 2030 (USD Million)
Fig. 14 Global Claims Data market, 2018 - 2030 (USD Million)
Fig. 15 Global Pharmacy Data market, 2018 - 2030 (USD Million)
Fig. 16 Global Patient-Powered Data market, 2018 - 2030 (USD Million)
Fig. 17 Global Pharmacy Data market, 2018 - 2030 (USD Million)
Fig. 18 Real World Evidence (RWE) Solutions market, application outlook key takeaways
Fig. 19 Real World Evidence (RWE) Solutions market: Application movement analysis
Fig. 20 Global Drug Development & Approvals market, 2018 - 2030 (USD Million)
Fig. 21 Global Medical Device Development & Approvals market, 2018 - 2030 (USD Million)
Fig. 22 Global Reimbursement/Coverage & Regulatory Decision Making market, 2018 - 2030 (USD Million)
Fig. 23 Global Post Market Safety & Adverse Events Monitoring market, 2018 - 2030 (USD Million)
Fig. 24 Real World Evidence (RWE) Solutions market, End-user outlook key takeaways
Fig. 25 Real World Evidence (RWE) Solutions market: End-use movement analysis
Fig. 26 Global Healthcare Companies (Pharmaceutical, Biopharmaceutical, Medical Device) market, 2018 - 2030 (USD Million)
Fig. 27 Global Healthcare Payers market, 2018 - 2030 (USD Million)
Fig. 28 Global Healthcare Providers market, 2018 - 2030 (USD Million)
Fig. 29 Global others market, 2018 - 2030 (USD Million)
Fig. 30 Real World Evidence (RWE) Solutions market, Therapeutic Area outlook key takeaways
Fig. 31 Real World Evidence (RWE) Solutions market: Therapeutic Area movement analysis
Fig. 32 Global Oncology market, 2018 - 2030 (USD Million)
Fig. 33 Global Cardiology market, 2018 - 2030 (USD Million)
Fig. 34 Global Neurology market, 2018 - 2030 (USD Million)
Fig. 35 Global Diabetes market, 2018 - 2030 (USD Million)
Fig. 36 Global Psychiatry market, 2018 - 2030 (USD Million)
Fig. 37 Global Respiratory market, 2018 - 2030 (USD Million)
Fig. 38 Global Other therapeutic areas market, 2018 - 2030 (USD Million)
Fig. 39 Regional market: Key takeaways
Fig. 40 Regional outlook, 2022 & 2030
Fig. 41 North America Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 42 U.S. Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 43 Canada Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 44 Europe Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 45 U.K. Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 46 Germany Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 47 France Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 48 Italy Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 49 Spain Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 50 Asia Pacific Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 51 Japan Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 52 China Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 53 India Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 54 Australia Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 55 South Korea Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 56 Latin America Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 57 Brazil Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 58 Mexico Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 59 Argentina Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 60 MEA Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 61 South Africa Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 62 Saudi Arabia Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 63 Israel Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 64 Strategy framework
Fig. 65 Participant categorization
Fig. 1 Market summary
Fig. 2 Market trends & outlook
Fig. 3 Market segmentation & scope
Fig. 4 Market driver relevance analysis (Current & future impact)
Fig. 5 Market restraint relevance analysis (Current & future impact)
Fig. 6 Penetration & growth prospect mapping
Fig. 7 SWOT Analysis, By Factor (political & legal, economic and technological)
Fig. 8 Real World Evidence (RWE) Solutions: Porter’s Analysis
Fig. 9 Real World Evidence (RWE) Solutions market, Component outlook key takeaways
Fig. 10 Real World Evidence (RWE) Solutions market: Component movement analysis
Fig. 11 Global Services market, 2018 - 2030 (USD Million)
Fig. 12 Global Data Sets market, 2018 - 2030 (USD Million)
Fig. 13 Global Clinical Settings Data market, 2018 - 2030 (USD Million)
Fig. 14 Global Claims Data market, 2018 - 2030 (USD Million)
Fig. 15 Global Pharmacy Data market, 2018 - 2030 (USD Million)
Fig. 16 Global Patient-Powered Data market, 2018 - 2030 (USD Million)
Fig. 17 Global Pharmacy Data market, 2018 - 2030 (USD Million)
Fig. 18 Real World Evidence (RWE) Solutions market, application outlook key takeaways
Fig. 19 Real World Evidence (RWE) Solutions market: Application movement analysis
Fig. 20 Global Drug Development & Approvals market, 2018 - 2030 (USD Million)
Fig. 21 Global Medical Device Development & Approvals market, 2018 - 2030 (USD Million)
Fig. 22 Global Reimbursement/Coverage & Regulatory Decision Making market, 2018 - 2030 (USD Million)
Fig. 23 Global Post Market Safety & Adverse Events Monitoring market, 2018 - 2030 (USD Million)
Fig. 24 Real World Evidence (RWE) Solutions market, End-user outlook key takeaways
Fig. 25 Real World Evidence (RWE) Solutions market: End-use movement analysis
Fig. 26 Global Healthcare Companies (Pharmaceutical, Biopharmaceutical, Medical Device) market, 2018 - 2030 (USD Million)
Fig. 27 Global Healthcare Payers market, 2018 - 2030 (USD Million)
Fig. 28 Global Healthcare Providers market, 2018 - 2030 (USD Million)
Fig. 29 Global others market, 2018 - 2030 (USD Million)
Fig. 30 Real World Evidence (RWE) Solutions market, Therapeutic Area outlook key takeaways
Fig. 31 Real World Evidence (RWE) Solutions market: Therapeutic Area movement analysis
Fig. 32 Global Oncology market, 2018 - 2030 (USD Million)
Fig. 33 Global Cardiology market, 2018 - 2030 (USD Million)
Fig. 34 Global Neurology market, 2018 - 2030 (USD Million)
Fig. 35 Global Diabetes market, 2018 - 2030 (USD Million)
Fig. 36 Global Psychiatry market, 2018 - 2030 (USD Million)
Fig. 37 Global Respiratory market, 2018 - 2030 (USD Million)
Fig. 38 Global Other therapeutic areas market, 2018 - 2030 (USD Million)
Fig. 39 Regional market: Key takeaways
Fig. 40 Regional outlook, 2022 & 2030
Fig. 41 North America Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 42 U.S. Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 43 Canada Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 44 Europe Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 45 U.K. Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 46 Germany Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 47 France Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 48 Italy Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 49 Spain Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 50 Asia Pacific Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 51 Japan Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 52 China Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 53 India Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 54 Australia Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 55 South Korea Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 56 Latin America Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 57 Brazil Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 58 Mexico Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 59 Argentina Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 60 MEA Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 61 South Africa Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 62 Saudi Arabia Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 63 Israel Real World Evidence (RWE) Solutions market, 2018 - 2030 (USD Million)
Fig. 64 Strategy framework
Fig. 65 Participant categorization
